Remove for-sales
article thumbnail

J&J reports strong sales numbers for Tecvayli, bolstering company's multiple myeloma 'stronghold'

Fierce Pharma

For the first time, Johnson & Johnson has reported sales numbers for its novel multiple myeloma treatment Tecvayli and they indicate that the bispecific, which was approved in October 2022, is | For the first time, Johnson & Johnson is reporting sales of its multiple myeloma drug Tecvayli, which is off to a strong launch and contributing to (..)

Sales 214
article thumbnail

With COVID sales in free-fall, Pfizer slashes revenue forecast by $9B and preps for major cost cuts

Fierce Pharma

The company now expects sales to reach between $58 billion and $61 billion, down from a prior range of $67 billion to $70 billion. The company now expects sales to reach between $58 billion and $61 billion, down from a prior range of $67 billion to $70 billion.

Sales 363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Stagnant sales for Dermavant's Vtama cast doubt on its blockbuster potential

Fierce Pharma

As a result, Leerink Partners has slashed its sales projections for the nonsteroidal topical treatment. In the market, however, Vtama is struggling to catch on. In the market, however, Vtama is struggling to catch on.

Sales 197
article thumbnail

UPDATED: Gearing up for key approvals, GSK projects 'Shingrix-like' sales for its RSV vaccine

Fierce Pharma

UPDATED: Gearing up for key approvals, GSK projects 'Shingrix-like' sales for its RSV vaccine fkansteiner Wed, 04/26/2023 - 09:52

Sales 266
article thumbnail

The Best Sales Forecasting Models for Weathering Your Goals

Every sales forecasting model has a different strength and predictability method. Your future sales forecast? It’s recommended to test out which one is best for your team. This way, you’ll be able to further enhance – and optimize – your newly-developed pipeline. Sunny skies (and success) are just ahead!

article thumbnail

Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales

Fierce Pharma

After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million deal | Merz Therapeutics, in a "stalking horse bid," agreed to pick up Acorda's Parkinson's disease med Inbrija and multiple sclerosis drug (..)

Sales 285
article thumbnail

Distributor Sales Training: Strategies For Building a High-Performing Sales Force

Spotio

Studies suggest that best-in-class companies close 30% of sales qualified leads , while average companies close 20%. Effective sales training. Every sales team needs solid training and ongoing coaching. If your sales team can’t close more than 20% of its deals, your company will probably struggle to stay in business.

article thumbnail

The 2019 Technographic Data Report for B2B Sales Organizations

In this report, ZoomInfo substantiates the assertion that technographic data is a vital resource for sales teams. The reason for this is simple—sales teams value technographic data because it makes essential selling activities easier and more efficient. In fact, the majority of respondents agree—with 72.3%

article thumbnail

16 Go-to-Market Plays for Your Entire Sales Funnel

Nurturing leads through your sales funnel is a daunting task for many business development teams, especially at the scale required to achieve lofty growth goals. That’s why we’ve gathered some of the best go-to-market plays from our own B2B sales and marketing pros and packaged them here for you.

article thumbnail

The Time-Saving Power of Intent Data for Sales

By using the power of intent data, capturing buyer interest has become more feasible for sales. Not only that, but using it will save immense time during your workflow; a win-win on all fronts. Read on to learn more about how intent data can save salespeople time -- while capturing more qualified leads in the process!

article thumbnail

Best Practices for Accelerating the Sales Process

More often than not, sales leaders strive to accelerate their deal cycle, but it’s critical to also consider the opportunity cost. The bottom line is that, in B2B sales, speed is useless without control. The bottom line is that, in B2B sales, speed is useless without control.

article thumbnail

B2B Pocket Playbook: End-to-End Guide to Sales Enablement

Sales enablement is the strategic process of providing sales teams with the content, guidance, and mentorship needed to engage targeted buyers. It’s all about equipping sales professionals with the tools they need to put their best-selling foot forward. Get started today.

article thumbnail

3 Sizzling Ways to Warm up Cold Calls

Even in today’s data-driven sales world, cold calling remains a fact of life for many go-to-market professionals. Fortunately, today’s sales leaders have a crucial advantage over their predecessors: market intelligence and outreach platforms that can warm up virtually any introduction.

article thumbnail

Pressure Points: How to Ensure Your B2B Pipeline Passes Inspection

This eBook highlights best practices for developing a pipeline management process that helps sales leaders and their team C.L.O.S.E you’ll see what we mean in this eBook) more revenue through data-driven prospecting, stage analysis, and subsequent sales enablement.

article thumbnail

5 Essential Pieces of a Prospecting Solution

Forward thinking sales leaders are starting to prioritize technology initiatives. As organizations chase new revenue targets, B2B sales leaders must examine cutting edge prospecting solutions that proactively help reps identify, connect with, and close qualified buyers faster.